Aiming to become the global leader in chip-scale photonic solutions by deploying Optical Interposer technology to enable the seamless integration of electronics and photonics for a broad range of vertical market applications

Free
Message: buyout

at least not all stocks are this boring

CML HealthCare Enters into an Arrangement Agreement with LifeLabs Medical Laboratory Services to Acquire the Outstanding Shares of CML

- Investor conference call today, June 25, 2013 at 9:00 a.m. EDT -

MISSISSAUGA, ONTARIO--(Marketwired - June 25, 2013) - CML HealthCare Inc. (TSX:CLC) (the "Company" or "CML"), announced today that it has entered into an Arrangement Agreement (the "Arrangement") with a newly formed Ontario corporation established by LifeLabs Inc., the general partner of LifeLabs Medical Laboratory Services ("LifeLabs"). LifeLabs is indirectly owned by OMERS Administration Corporation ("OMERS"), whose interest is managed by Borealis Infrastructure ("Borealis"). The Arrangement provides for the acquisition of all issued and outstanding shares of CML for $10.75 per share in cash by way of a Plan of Arrangement under the Business Corporations Act (Ontario). The total transaction, including the assumption of CML's outstanding debt of $255 million at March 31, 2013, is valued at approximately $1.22 billion.

The $10.75 in cash per common share that CML shareholders will receive under the terms of the Arrangement, represents a 49.3% premium to CML's closing price of $7.20 on June 24, 2013, and a 47.0% premium to the 20-day volume-weighted average share price based on trading on the Toronto Stock Exchange.


Jun 25, 2013 12:09PM

Jun 25, 2013 12:30PM
1
Jun 25, 2013 12:34PM

Jun 25, 2013 12:39PM
1
Jun 25, 2013 12:55PM
Share
New Message
Please login to post a reply